Catherine Roche

544 total citations
24 papers, 428 citations indexed

About

Catherine Roche is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Catherine Roche has authored 24 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Genetics. Recurrent topics in Catherine Roche's work include Neuroendocrine Tumor Research Advances (6 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Catherine Roche is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Catherine Roche collaborates with scholars based in France, Morocco and Germany. Catherine Roche's co-authors include Dimitri Lavillette, Stephen J. Russell, Marc Sitbon, Marielle Maurice, François–Loïc Cosset, Anne Barlier, Dominique Figarella‐Branger, A Enjalbert, P. Richard and Yves Brunet and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer Research.

In The Last Decade

Catherine Roche

24 papers receiving 420 citations

Peers

Catherine Roche

EPIDE

EDM

ONCOL

GPC

Masato Sasaki Japan

Gladis Shuttlesworth United States

Á Okamura Japan

Y Takahashi Japan

Helen Marshall United Kingdom

Chiara Conte Italy

Thomas O. Robbins United States

Timothy D. Murtha United States

J.F. Smith New Zealand

Matteo Megna Italy

Masato Sasaki Japan

Catherine Roche

85 ×0.7

EPIDE

221 ×2.1

45 ×0.5

EDM

104 ×1.2

ONCOL

45 ×0.6

GPC

Citations per year, relative to Catherine Roche Catherine Roche (= 1×) peers Masato Sasaki

Countries citing papers authored by Catherine Roche

Since Specialization

Citations

This map shows the geographic impact of Catherine Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Roche more than expected).

Fields of papers citing papers by Catherine Roche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Roche. The network helps show where Catherine Roche may publish in the future.

Co-authorship network of co-authors of Catherine Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Roche. A scholar is included among the top collaborators of Catherine Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Roche. Catherine Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roche, Catherine, Romain Appay, Henry Dufour, et al.. (2022). Co-Targeting MAP Kinase and Pi3K-Akt-mTOR Pathways in Meningioma: Preclinical Study of Alpelisib and Trametinib. Cancers. 14(18). 4448–4448. 8 indexed citations

Romanet, Pauline, Justine Galluso, Peter Kamenický, et al.. (2021). Somatotroph Tumors and the Epigenetic Status of the GNAS Locus. International Journal of Molecular Sciences. 22(14). 7570–7570. 11 indexed citations

Gérard, Corinne, Flora Poizat, Sandrine Oziel-Taïeb, et al.. (2020). Kinome rewiring during acquired drug resistance in neuroendocrine neoplasms. Endocrine Related Cancer. 28(1). 39–51. 2 indexed citations

Roche, Catherine, et al.. (2019). OS8.7 Targeting Pi3k-Akt-mTOR and MAPKinase pathways in aggressive meningiomas: in vitro study. Neuro-Oncology. 21(Supplement_3). iii17–iii17. 2 indexed citations

Philibert, Pascal, Thomas Cuny, Catherine Roche, et al.. (2018). Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations

Romanet, Pauline, Pascal Philibert, Fréderic Fina, et al.. (2018). Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome. The Journal of Pediatrics. 205. 281–285.e4. 17 indexed citations

Mohamed, Amira, David Romano, Alexandru Saveanu, et al.. (2017). Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?. Oncotarget. 8(25). 41044–41063. 21 indexed citations

Cuny, Thomas, Martin Bidlingmaier, Céline Defilles, et al.. (2016). In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells. Endocrine Related Cancer. 23(7). 509–519. 8 indexed citations

Jullien, Nicolas, Catherine Roche, Thierry Brue, et al.. (2015). Dose-Dependent Dual Role of PIT-1 (POU1F1) in Somatolactotroph Cell Proliferation and Apoptosis. PLoS ONE. 10(3). e0120010–e0120010. 2 indexed citations

10.

Chalabi‐Dchar, Mounira, Stéphanie Cassant‐Sourdy, Camille Duluc, et al.. (2015). Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16. Gastroenterology. 148(7). 1452–1465. 35 indexed citations

11.

Cuny, Thomas, Amira Mohamed, Thomas Graillon, et al.. (2012). Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: Impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion. Molecular and Cellular Endocrinology. 355(1). 106–113. 21 indexed citations

12.

Roche, Catherine, Ramahefarizo Rasolonjanahary, Sylvie Thirion, et al.. (2011). Inactivation of Transcription Factor Pit-1 to Target Tumoral Somatolactotroph Cells. Human Gene Therapy. 23(1). 104–114. 8 indexed citations

13.

Acunzo, Julie, Catherine Roche, Céline Defilles, et al.. (2011). Inactivation of PITX2 Transcription Factor Induced Apoptosis of Gonadotroph Tumoral Cells. Endocrinology. 152(10). 3884–3892. 20 indexed citations

14.

Timinouni, Mohammed, et al.. (2009). RET genetic screening in patients with medullary thyroid cancer: The Moroccan experience. Journal of Cancer Research and Therapeutics. 5(3). 198–198. 9 indexed citations

15.

Acunzo, Julie, Sylvie Thirion, Catherine Roche, et al.. (2008). Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas. Cancer Research. 68(24). 10163–10170. 35 indexed citations

16.

Ayzac, Louis, et al.. (2008). Présentation de Dialin : réseau de surveillance des infections chez les patients hémodialysés en centre. Premiers résultats. Néphrologie & Thérapeutique. 5(1). 41–51. 3 indexed citations

17.

Roche, Catherine, A.J. Zamora, David Taïeb, et al.. (2004). Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters. Journal of Endocrinology. 183(1). 217–233. 10 indexed citations

18.

Ogée, Jérôme, Philippe Peylin, Philippe Ciais, et al.. (2003). Partitioning net ecosystem carbon exchange into net assimilation and respiration using ¹³CO₂ measurements: A cost‐effective sampling strategy. Global Biogeochemical Cycles. 17(2). 81 indexed citations

19.

Martínez-Bermejo, A, et al.. (2002). Enfermedad de Lafora. Confirmación diagnóstica por genética molecular de un nuevo caso.. Revista de Neurología. 34(2). 117–117. 1 indexed citations

20.

Hervé, P, Pierre Bordigoni, J Cahn, et al.. (1991). Use of monoclonal antibodies in vivo as a therapeutic strategy for acute GvHD in matched and mismatched bone marrow transplantation.. PubMed. 23(1 Pt 2). 1692–4. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact